Omega-3 Fatty Acids Supplementation in the Treatment of Depression: An Observational Study
- PMID: 36836458
- PMCID: PMC9962071
- DOI: 10.3390/jpm13020224
Omega-3 Fatty Acids Supplementation in the Treatment of Depression: An Observational Study
Abstract
Depression is a common mood disorder characterized by persistent sadness and loss of interest. Research suggests an association between the inclusion of omega-3 fatty acids in the diet and a reduced risk for depression. The present study evaluated the effectiveness of omega-3 fatty acid supplements in alleviating depressive symptoms in patients with mild to moderate depression. A total of 165 patients suffering from mild to moderated depression were randomized to receive omega-3 fatty acid supplementation, an antidepressant (single agent), or a combination of an antidepressant and omega-3 fatty acid supplementation. The clinical features of depression were assessed using the Hamilton Depression Rating Scale (HDRS) during the follow-up period. A statistically significant improvement in depressive symptoms was observed from baseline to first, second and third follow-ups within each treatment arm as measured by HRDS scores (p = 0.00001). Further, the HDRS scores at the third follow-up were significantly lower in patients on combination therapy of omega-3 fatty acid supplement and antidepressants (arm-3) than the patients on the omega-3 fatty acid supplement alone (arm-1) [Q = 5.89; p = 0.0001] or the patients taking an antidepressant alone (arm 2) [Q = 4.36; p = 0.0068]. The combination of an omega-3 fatty acid supplement and an antidepressant elicited significantly higher improvement in depressive symptoms than the supplement or the antidepressant alone.
Keywords: adjunct therapy; antidepressants; depression; mental health; omega-3 fatty acids.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Omega-3 fatty acids from Supplements Consumed before and during Pregnancy and Lactation and Developmental Milestones, Including Neurocognitive Development, in the Child: A Systematic Review [Internet].Alexandria (VA): USDA Nutrition Evidence Systematic Review; 2020 Jul. Alexandria (VA): USDA Nutrition Evidence Systematic Review; 2020 Jul. PMID: 35289988 Free Books & Documents. Review.
-
Effect of Omega-3 Fatty Acids on Depressive Symptoms in HIV-Positive Individuals: A Randomized, Placebo-Controlled Clinical Trial.Ann Pharmacother. 2016 Oct;50(10):797-807. doi: 10.1177/1060028016656017. Epub 2016 Jun 20. Ann Pharmacother. 2016. PMID: 27323793 Clinical Trial.
-
[Augmentation of antidepressants with unsaturated fatty acids omega-3 in drug-resistant depression].Psychiatr Pol. 2012 Jul-Aug;46(4):585-98. Psychiatr Pol. 2012. PMID: 23214161 Polish.
-
Omega-3 fatty acids in depression: a review of three studies.CNS Neurosci Ther. 2009 Summer;15(2):128-33. doi: 10.1111/j.1755-5949.2008.00061.x. CNS Neurosci Ther. 2009. PMID: 19499625 Free PMC article. Review.
-
Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study.Health Technol Assess. 2009 Apr;13(22):iii-iv, ix-xi, 1-159. doi: 10.3310/hta13220. Health Technol Assess. 2009. PMID: 19401066 Clinical Trial.
Cited by
-
Omega-3 Fatty Acids for Depression in the Elderly and Patients with Dementia: A Systematic Review and Meta-Analysis.Healthcare (Basel). 2024 Feb 23;12(5):536. doi: 10.3390/healthcare12050536. Healthcare (Basel). 2024. PMID: 38470647 Free PMC article. Review.
-
Neutrophil-to-lymphocyte ratio as a predictive biomarker for early diagnosis of depression: A narrative review.Brain Behav Immun Health. 2024 Feb 5;36:100734. doi: 10.1016/j.bbih.2024.100734. eCollection 2024 Mar. Brain Behav Immun Health. 2024. PMID: 38362135 Free PMC article. Review.
-
Evaluation of Antidepressant Activity of Capsaicin Nanoemulsion in Nicotine Withdrawal-Induced Depression in Mice.Brain Sci. 2023 Dec 1;13(12):1668. doi: 10.3390/brainsci13121668. Brain Sci. 2023. PMID: 38137115 Free PMC article.
-
Personalized Medicine of Omega-3 Fatty Acids in Depression Treatment in Obese and Metabolically Dysregulated Patients.J Pers Med. 2023 Jun 15;13(6):1003. doi: 10.3390/jpm13061003. J Pers Med. 2023. PMID: 37373992 Free PMC article. Review.
-
Prevalence of Cognitive Decline in Type 2 Diabetes Mellitus Patients: A Real-World Cross-Sectional Study in Mysuru, India.J Pers Med. 2023 Mar 15;13(3):524. doi: 10.3390/jpm13030524. J Pers Med. 2023. PMID: 36983706 Free PMC article.
References
-
- WHO Fact Sheet Depression. [(accessed on 24 November 2022)]. Available online: https://www.who.int/news-room/fact-sheets/detail/depression.
-
- Sinha P., Hussain T., Boora N.K., Rao G.N., Varghese M., Gururaj g., Benegal V., NMHS India Collaborators Group Prevalence of Common mental disorders in older adults: Results from the National Mental Health Survey of India. Asian J. Psychiatry. 2021;55:102463. doi: 10.1016/j.ajp.2020.102463. - DOI - PubMed
-
- Mehdi S., Manohar K., Shariff A., Wani S.U.D., Almuqbil M., Alshehri S., Shakeel F., Imam M.T., Krishna K.L. Analysis of Antidepressants Utilization for Patients Visiting Psychiatric Out-Patient Clinic in a Tertiary Care Hospital. Healthcare. 2022;10:2081. doi: 10.3390/healthcare10102081. - DOI - PMC - PubMed
-
- Kearns B., Cooper K., Orr M., Essat M., Hamilton J., Cantrell A. The Incidence and Costs of Adverse Events Associated with Antidepressants: Results from a Systematic Review, Network Meta-Analysis and Multi-Country Economic Model. Neuropsychiatr. Dis. Treat. 2022;ume 18:1133–1143. doi: 10.2147/NDT.S356414. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources